Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Haruna Kawano"'
Autor:
Shuji Isotani, Peter Ka-Fung Chiu, Takeshi Ashizawa, Yan-Ho Fung, Takeshi Ieda, Toshiyuki China, Haruna Kawano, Fumitaka Shimizu, Masayoshi Nagata, Yuki Nakagawa, Satoru Muto, Ka-Leung Wong, Chi-Fai Ng, Shigeo Horie
Publikováno v:
Prostate International, Vol 11, Iss 3, Pp 180-185 (2023)
Objectives: To investigate the role of urine spermine and spermine risk score in predicting prostate cancer (PCa) diagnoses in combination with multiparametric magnetic resonance imaging (mpMRI). Methods: Three hundred forty seven consecutive men wit
Externí odkaz:
https://doaj.org/article/413dbcf5ae724b9382cce1fafa6bfecc
Autor:
Hisashi Hirano, Masayoshi Nagata, Naoya Nagaya, So Nakamura, Takeshi Ashizawa, Yan Lu, Haruna Kawano, Kosuke Kitamura, Yoshiro Sakamoto, Kazuhiko Fujita, Hideyuki Isobe, Akira Tsujimura, Satoru Muto, Shigeo Horie
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract Reports of Bone Scan Index (BSI) calculations as imaging biomarkers to predict survival in patients with metastatic castration-resistant prostate cancer (mCRPC) have been mainly from retrospective studies. To evaluate the effectiveness of en
Externí odkaz:
https://doaj.org/article/47e989c297554e0ba6909ec03f3753b7
Autor:
Mai Yamazaki, Haruna Kawano, Miho Miyoshi, Tomoki Kimura, Keiji Takahashi, Satoru Muto, Shigeo Horie
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2088 (2024)
Tolvaptan, an oral vasopressin V2 receptor antagonist, reduces renal volume expansion and loss of renal function in patients with autosomal dominant polycystic kidney disease (ADPKD). Data for predictive factors indicating patients more likely to ben
Externí odkaz:
https://doaj.org/article/1d2f09ecf4df4f9eabcafae9e1c700a5
Autor:
Reo Hamaguchi, Yoshihiro Hirokawa, Hirotsugu Takahashi, Tsuyoshi Hachiya, Haruna Kawano, Shuji Isotani, Emi Ito, Nobuhiro Handa, Ryozo Saito, Shigeo Horie, Hisamitsu Ide
Publikováno v:
Frontiers in Digital Health, Vol 5 (2023)
IntroductionIn this study, we aimed to evaluate the feasibility, utility, and potential effects of LQ-M/D App, a smartphone application developed by Life Quest Inc., Tokyo, Japan, for patients with mild cognitive impairment (MCI) and mild dementia. T
Externí odkaz:
https://doaj.org/article/279ebe6468a2430c903e7144e8c3fb11
Autor:
Tomoki Kimura, Haruna Kawano, Satoru Muto, Nobuhito Muramoto, Toshiaki Takano, Yan Lu, Hidetaka Eguchi, Hiroo Wada, Yasushi Okazaki, Hisamitsu Ide, Shigeo Horie
Publikováno v:
Biomolecules, Vol 13, Iss 7, p 1020 (2023)
Background: Autosomal dominant polycystic kidney disease (ADPKD) occurs in 1 in 500–4000 people worldwide. Genetic mutation is a biomarker for predicting renal dysfunction in patients with ADPKD. In this study, we performed a genetic analysis of Ja
Externí odkaz:
https://doaj.org/article/bcf0d327bd904621ad87dd3f684f31c3
Autor:
Akinari Sekine, Sumi Hidaka, Tomofumi Moriyama, Yasuto Shikida, Keiji Shimazu, Eiji Ishikawa, Kiyotaka Uchiyama, Hiroshi Kataoka, Haruna Kawano, Mahiro Kurashige, Mai Sato, Tatsuya Suwabe, Shinya Nakatani, Tadashi Otsuka, Hirayasu Kai, Kan Katayama, Shiho Makabe, Shun Manabe, Wataru Shimabukuro, Koichi Nakanishi, Saori Nishio, Fumihiko Hattanda, Kazushige Hanaoka, Kenichiro Miura, Hiroki Hayashi, Junichi Hoshino, Ken Tsuchiya, Toshio Mochizuki, Shigeo Horie, Ichiei Narita, Satoru Muto
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 21, p 6528 (2022)
Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cystic kidney disease, with patients often having a positive family history that is characterized by a similar phenotype. However, in atypical cases, particularly thos
Externí odkaz:
https://doaj.org/article/f6f709b5fc3349d2bb527a1d4e5996b9
Autor:
Moritoshi Kinoshita, Eiji Higashihara, Haruna Kawano, Ryo Higashiyama, Daisuke Koga, Takafumi Fukui, Nobuhisa Gondo, Takehiko Oka, Kozo Kawahara, Krisztina Rigo, Tim Hague, Kiyonori Katsuragi, Kimiyoshi Sudo, Masahiko Takeshi, Shigeo Horie, Kikuo Nutahara
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0166288 (2016)
Genetic testing of PKD1 and PKD2 is expected to play an increasingly important role in determining allelic influences in autosomal dominant polycystic kidney disease (ADPKD) in the near future. However, to date, genetic testing is not commonly employ
Externí odkaz:
https://doaj.org/article/852e2aefe090466e906eba4ce22fc7eb
Autor:
Yoshihiro Ikehata, Yuki Nakagawa, Katsuhito Yuzawa, Tomoya Shirakawa, Azusa Yoshiyama, So Nakamura, Yuki Nagashima, Keisuke Ishikawa, Naoya Nagaya, Takeshi Ashizawa, Toshiyuki China, Haruna Kawano, Fumitaka Shimizu, Masayoshi Nagata, Shuji Isotani, Satoru Muto, Masayuki Maiguma, Yusuke Suzuki, Shigeo Horie
Publikováno v:
Transplantation Proceedings. 54:2754-2757
Thrombophilia causes thrombosis after kidney transplantation (KT). Protein C deficiency is a rare form of hereditary thrombophilia. To our knowledge, there are few reports on KT for patients with protein C deficiency, and there are no reports of KT i
Autor:
Horie, Tomoki Kimura, Haruna Kawano, Satoru Muto, Nobuhito Muramoto, Toshiaki Takano, Yan Lu, Hidetaka Eguchi, Hiroo Wada, Yasushi Okazaki, Hisamitsu Ide, Shigeo
Publikováno v:
Biomolecules; Volume 13; Issue 7; Pages: 1020
Background: Autosomal dominant polycystic kidney disease (ADPKD) occurs in 1 in 500–4000 people worldwide. Genetic mutation is a biomarker for predicting renal dysfunction in patients with ADPKD. In this study, we performed a genetic analysis of Ja
Autor:
Mitsuhiro Tambo, Shigeo Horie, Shinya Kaname, Toshihito Furukawa, Tatsuya Yoshioka, Satoru Taguchi, Tsuyoshi Yamaguchi, Haruna Kawano, Eiji Higashihara, Satoru Muto, Hiroshi Fukuhara, Kenich Yokoyama
Publikováno v:
American Journal of Nephrology. 51:881-890
Background: Tolvaptan was approved for the treatment of autosomal dominant polycystic kidney disease (ADPKD). However, the official indication of “rapidly progressive disease” is described differently in the clinical guidelines. We aim to define